Edition:
United Kingdom

Ono Pharmaceutical Co Ltd (4528.T)

4528.T on Tokyo Stock Exchange

2,569JPY
2:29am GMT
Change (% chg)

¥-46 (-1.78%)
Prev Close
¥2,616
Open
¥2,626
Day's High
¥2,628
Day's Low
¥2,564
Volume
734,100
Avg. Vol
2,005,568
52-wk High
¥3,430
52-wk Low
¥2,457

Chart for

About

ONO PHARMACEUTICAL CO., LTD. is a Japan-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates in one business segment. The Pharmaceutical segment involves in the manufacture and sale of drugs for medical and general use. The Company also involves in the clinical development,... (more)

Overall

Beta: 0.46
Market Cap(Mil.): ¥1,507,859.00
Shares Outstanding(Mil.): 589.24
Dividend: 20.00
Yield (%): 1.56

Financials

  4528.T Industry Sector
P/E (TTM): 25.15 31.13 33.63
EPS (TTM): 101.76 -- --
ROI: 10.83 15.55 15.02
ROE: 11.02 16.92 16.60

Nikkei rises to new 27-year high as earnings hopes underpin mood; Ono Pharma soars

TOKYO, Oct 2 Japan's Nikkei advanced to a fresh 27-year high on Tuesday as stronger earnings hopes underpinned sentiment, while Ono Pharmaceutical jumped on news that a Nobel Prize was awarded to researchers for a cancer-fighting method used in its drug Opdivo.

02 Oct 2018

Ono Pharma shares soar; Nobel awarded for cancer-fighting method used in its drug

TOKYO Shares of Ono Pharmaceutical Co jumped to levels not seen in over two years after a Nobel Prize was awarded to researchers for a cancer-fighting method used in Opdivo, a drug it co-developed with Bristol-Myers Squibb Co.

02 Oct 2018

Ono Pharma shares soar; Nobel awarded for cancer-fighting method used in its drug

TOKYO Shares of Ono Pharmaceutical Co jumped to levels not seen in over two years after a Nobel Prize was awarded to researchers for a cancer-fighting method used in Opdivo, a drug it co-developed with Bristol-Myers Squibb Co .

02 Oct 2018

Ono Pharma shares soar; Nobel awarded for cancer-fighting method used in its drug

TOKYO, Oct 2 Shares of Ono Pharmaceutical Co jumped to levels not seen in over two years after a Nobel Prize was awarded to researchers for a cancer-fighting method used in Opdivo, a drug it co-developed with Bristol-Myers Squibb Co.

02 Oct 2018

Earnings vs. Estimates